-HFIP-treated-Peptide.jpg)
Beta-Amyloid 1-42 HFIP treated
Description
About Beta-Amyloid 1-42 HFIP treated
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (Swiss-Prot ID: P05067). HFIP treatment is performed to disrupt beta-sheets and other unwanted secondary structures.
Beta-Amyloid 1-42 HFIP treated - Specifications
Peptide Sequence: DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIAProtein Name: Amyloid beta (A4) (alternative names: Abeta, Beta amyloid, APP)
- Purity: >95% (HPLC-MS)
- Delivery Format: Freeze-dried in plastic vial
- Application(s):
- Condition(s)/Topic(s): Alzheimer's disease
- Standard Delivery Time: approx. 3 weeks
Applications in Alzheimer Disease Research
Beta amyloid 1-42 is a crucial component in:- Understanding Alzheimer Pathogenesis: Understanding the aggregation of amyloid plaques in neural tissues.
- Drug Discovery: Screening and testing potential therapeutic agents that target amyloid beta aggregation.
- Biomarker Development: Identifying early-stage biomarkers for Alzheimer's diagnosis.
Customization for Your Research Needs
At JPT Peptide Technologies, we understand that every research project has unique requirements. We offer tailored peptide synthesis services to match your specific needs, whether its beta amyloid 1-42, amyloid beta 1-42, or other variants of amyloid beta peptides. Choose your preferred sequence, amount, and purity, and our expert team will guide you through the process to ensure optimal results.
Why Choose JPT Peptide Technologies?
With over two decades of peptide synthesis expertise, JPT stands out for quality and precision. Our beta amyloid 1-42 peptides are produced under stringent quality standards at our ISO-certified facility in Berlin.
What Sets Us Apart:Explore More Peptide Tools for Alzheimer's Research
Visit our webpage to explore a wide range of peptide tools designed specifically for Alzheimer's disease research. Whether you need other Abeta peptides, custom modifications, or detailed consultation, we are here to assist you every step of the way.
Visit our webpage for more Peptide Tools to Study Alzheimer's Disease
Are you interested in your other Abeta Peptides? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.
References
References for Beta-Amyloid 1-42 HFIP treated
References:
Read References with Amyloid Beta A4 Peptides (abeta, aß)
Application Note
Synthetic Amyloid Beta Peptides Aid Alzheimer Investigation
Broersen et al., Application Note (2013) (full text)
Testimonial
“Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source. We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle.”
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands
Documentation
Documentation for Beta-Amyloid 1-42 HFIP treated
Properties
Properties of Beta-Amyloid 1-42 HFIP treated
Properties | Values |
---|---|
Category: | Abeta Peptides |
Condition / Topic: | Alzheimer's disease |
Layout: | Freeze-dried in plastic vial |
Organism: | Human |
Protein Name: | Amyloid beta (A4) protein |
Purity: | >95% (HPLC-MS) |
Quantification: | No, Yes |
Further Information to Beta-Amyloid 1-42 HFIP treated
Information | Values |
---|---|
Sequence: | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
Specifications: | Synthetic Beta-Amyloid peptide (1-42) |